Back to feeds

Meet the doctor from Punjab who built a 30,000 CR company. 1. Born in the ancient city of Batala in Punjab to a gynaecologist mom and ENT specialist father, Naresh Trehan always wanted to be a doctor. His dream came true when he completed his MBBS at Lucknow's King George Medical College. Dr Trehan was in a league of his own. 🙌 2. He moved to the USA and started working at New York's Grossman School of Medicine. He started getting recognised for his coronary bypass surgery and became a respected name in the Indo-US community. But still, Trehan missed India and wanted to come back. 3. By 1988, he had returned and, with HP Nanda, had set up India's first heart institute, the Escorts Heart Institute and Research Centre. The project became such a hit that Fortis Healthcare bought a 90% stake for Rs 650 CR in September 2006. But Dr Trehan was still thinking something. 🤔 4. He wanted to develop a medical institute that pioneered quality research alongside healthcare services. In 2009, he started a 1250-bed super-speciality hospital spread over 43 acres in Gurgaon, Haryana. Medanta was born. 🚀 5. His idea was simple ⏩ Build Medanta based on the Mayo Clinic model, where all the super speciality teams are on a single platform with a team of doctors and paramedics. However, he knew the need for proper pricing for the model to survive in India and had an idea. 💡 6. He combined traditional Ayurveda herb medicines to reduce the surgery cost to Rs 3.2 lakh when the global average was Rs 40 Lakhs. He also hired full-time doctors and trained them to become specialists. As it scaled to a revenue of 1200 CR by 2013, it raised 960 CR from PE firm Carlyle Group at a valuation of 3550 CR. 💰 7. Apart from cost, Medanta grew with solid fundamentals. Its enterprise value per bed was Rs 2.8 CR, compared to Rs 1.4 CR for Apollo and Fortis. By 2015, it opened its second 160-bed hospital in Indore with 64 ICU beds, five ICUs, four operation theatres, and a cath lab. ✅ 8. Dr Trehan knew that 16% of his patients were foreign nationals, so he started a medical value travel model with integrated insurance and multilingual support. As it scaled to 10,000 yearly patients from 100+ countries and touched a revenue of 1478.16 CR by 2021, the big moment came the following year. 👇 9. On 16 November 2022, Medanta was listed on the stock market with its 2,205.57 CR IPO, which was oversubscribed 9.58 times. It scaled to 4 hospitals, 1,300 doctors, 2467 beds, 30 specialities and a unicorn worth 8,880 CR. 🦄 10. Today, Medanta has a revenue of 3349 CR and a profit of 478 CR. It has expanded to 5 hospitals, 3841 beds, and 650 ICUs, treating over 25 lakh patients annually. It is worth 29,937 CR. 💪 ➡️ Padma Bhushan Dr Naresh Trehan still treats over 48,190 patients, worth a medical expenditure of 38.9 CR free of charge annually. 🙏